Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920097 · ClinicalTrials.gov registry record · NA
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
A NA study of Chemotherapy-induced Neuropathy, sponsored by The University of Texas Health Science Center, Houston.
- Active
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 2
- Study locations
NCT04920097: Active NA study of Chemotherapy-induced Neuropathy, sponsored by The University of Texas Health Science Center, Houston.
NCT04920097 is a NA study of Chemotherapy-induced Neuropathy that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 225 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04920097, a NA study of Chemotherapy-induced Neuropathy, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neuro-imaging to investigate APA's efficacy and underlying mechanism(s).
Primary Outcome
Brief Pain Inventory (BPI) assesses worst pain severity. The scale ranges from 0 (no pain) to 10 (severe pain), a higher score indicates greater pain
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER In-person training for seed placement and APA
- OTHER Virtual training for seed placement and APA
- OTHER Post-training zoom session for seed placement and APA coaching
Study Locations (2)
Maryland
- Johns Hopkins University - Baltimore
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2021-07-08 |
| Est. Completion | 2026-05-30 |
| Phase | NA |
What the registry record for NCT04920097 still lists
NCT04920097 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Chemotherapy-induced Neuropathy appearing as the primary indexed condition, and to 4 interventions - of which Usual Care is the first listed.
NCT04920097 reports a single indexed study location in Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT04920097 about?
NCT04920097 is a clinical study titled "Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy". The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neur...
What is the current status of trial NCT04920097?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2021-07-08. Estimated completion is 2026-05-30.
What conditions does trial NCT04920097 study?
This clinical trial studies the following conditions: Chemotherapy-induced Neuropathy.
What interventions are being tested in trial NCT04920097?
The interventions under investigation include: Usual Care (OTHER), In-person training for seed placement and APA (OTHER), Virtual training for seed placement and APA (OTHER), Post-training zoom session for seed placement and APA coaching (OTHER).
Who is sponsoring clinical trial NCT04920097?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04920097 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chemotherapy-induced Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04920097's enrollment target sits among peer trials
225 472nd of 2000 higher than 1,523 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI